ADVENZYMESFinancial ResultsBSE
Board Meeting Intimation for The Approval Of Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2026
Filed 23 October 2026 at 11:00 am · 17h ago
FILING SUBJECT
Board Meeting Intimation for The Approval Of Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2026